2017 - Hall-Perrine Cancer Center · of their survivorship care plan. The care plan is a summary of the stage and type of their prostate cancer, treatment details and recommendations

2017Hall-Perrine Cancer Center Community Report

2 2017 HALL-PERRINE CANCER CENTER COMMUNITY REPORT

A Note for the Community From the Medical Director of Hall-Perrine Cancer Center

Dear Friends,

I can’t help but reflect on fiscal year 2017 with tremendous pride at the advancements in cancer treatment we’ve ushered in.

One exciting progression came with the advancement of TomoTherapy™ HDA radiation technology. Treating approximately 20 patients each day, this state-of-the-art, image-guided technology integrates computed tomography scans to perform daily imaging before each treatment session. Its precision minimizes radiation exposure to surrounding healthy tissue and patients often experience fewer side effects.

Last year, Hall-Perrine Cancer Center was the first in Cedar Rapids (and in Iowa) to use SAVI SCOUT® technology as a standard of care for breast-cancer surgery patients. An alternative to wire localization, SAVI SCOUT is an FDA-cleared device used by surgeons and radiologists to precisely locate and direct the removal of a tumor during a lumpectomy or surgical biopsy procedure. The technology also allows surgeons to more strategically place the incision, helping reduce the discomfort associated with needle localization lumpectomy and resulting in better cosmetic outcomes. We’re already seeing great results.

An exciting honor came in April when we published our MarginProbe® data in the American Journal of Surgery. In our comparison of this technology to full-cavity shavings, results proved MarginProbe has significantly lowered lumpectomy re-excision rates by as much as 57 percent and reduced the volume of overall tissue removal by 32 percent.

This fiscal year also:

✓ Welcomed Ann Stroh, DO, to Oncology Associates, expanding the medical oncology program.

✓ Launched the G-Tube Clinic — a nurse practitioner, nurse, dietitian and speech therapist led team that assists with management and coordination of enteral feeding devises for those struggling to maintain adequate nutrition during cancer treatment.

✓ Introduced a new pre-swallow evaluation – assesses the swallowing function of head and neck cancer patients, and teaches exercises to help reduce changes, encouraging safe eating and drinking.

✓ Received reaccreditations from the Commission on Cancer (CoC), American College of Radiation Oncology (ACRO) and Quality Oncology Practice Initiative (QOPI) Certification Program. Each one of these accreditations is a national indication of our center’s quality care.

✓ Marked five years of comprehensive cancer care under the roof of Hall-Perrine Cancer Center.

It’s been a year of remarkable growth. I look forward to what the year ahead will bring.

Sincerely,

Vincent Reid, MD, FACSDirector of Surgical OncologyMedical Director, Hall-Perrine Cancer Center

Vincent Reid, MD, FACSMedical DirectorHall-Perrine Cancer Center

32017 HALL-PERRINE CANCER CENTER COMMUNITY REPORT

On Behalf of the 2017 Cancer Committee

The Cancer Committee is a multidisciplinary committee of Hall-Perrine Cancer Center Medical Staff. The committee meets quarterly to provide leadership for the cancer activities at the medical center and oversee the operations of the Cancer Registry. The Cancer Committee is involved in evaluating new technologies, establishing new programs and making recommendations for improving cancer care within the healthcare community.

CHAIRMAN

Vincent Reid, MDSurgical Oncologist, Hall-Perrine Cancer Center Medical Director

COMMITTEE MEMBERS

Vincent Reid, MD, Chair, Surgical Oncologist

Julie Netser, MD, Pathologist

Janet Merfeld, MD, Radiation Oncologist

Ann Stroh, DO Cancer Liaison, Medical Oncologist

Jasmine Nabi, MD, Medical Oncologist

Laura Hemann, MD, Radiologist

Rita Harris, Cancer Program Administrator

Tami Mason, Clinical Research Coordinator

Gwen Herder, Community Outreach Coordinator

Lauren Hansen, Cancer Registry Quality Coordinator, Certified Tumor Registrar

Leanne Thrapp, Palliative Care Team Member

Peg Weston-Kolarik, Social Worker, Psychosocial Services Coordinator

Jeanne Noble, Oncology Nurse Manager

Sallie Buelow, Cancer Conference Coordinator

Amy Yoder, Quality Improvement Coordinator

Amie Hass, ARNP, Genetic Counselor

Stephanie Miller, Survivorship ARNP

Dean Abramson, MD, Gastroenterologist

Arun Movva, MD, Endocrinology

Ken Cearlock, MD, Hospice & Palliative Care

Ronald Reider, MD, Medicine/Geriatrics

Matthew Smith, MD, Urologist

Shane Gailushas, MD, ENT Surgeon

Deborah Wilbur, MD, Medical Oncologist

Wook Lee, MD, Radiation Oncologist

Nora Royer, MD, General Surgery

Michelle Cooley, MD, Pathologist

Arnold Honik, MD, Radiologist

Eduardo Celis, MD, Pulmonologist

Aimee Bell, Clinical Supervisor

Nicole Sorge, Hall Radiation Center

Lou Ann Weber, Rehab Services

Stephanie Gioimo, Oncology Nurse Navigator

Nancy Jolliffe, Oncology Dietitian

Tammy Buseman, Pastoral Care

Shelly Walker, Amer. Cancer Society

Kristina Amerman, Clinical Research

Penny Glanz, VP Outpatient Operations

Kathie Churchill, Cancer Registrar

Joan Ortega, Social Worker

Kim Salzbrenner, Hall Radiation Center

Lisa Shaffer, ARNP, OCN

Molly Flynn, Director, Specialty Clinics

Becky Prier, Zone 41


2017 FOCUS: PROSTATE CANCEROther than skin cancer, prostate cancer is the most common cancer in American men. The American Cancer Society’s estimates for prostate cancer in the United States for 2017 are about 161,360 new cases of prostate cancer and about 26,730 deaths from prostate cancer. About 1 man in 7 will be diagnosed with prostate cancer during his lifetime.

Prostate cancer begins when cells in the prostate gland start to grow uncontrollably. The prostate is a gland found only in males. It makes some of the fluid that is part of semen. The prostate is below the bladder and in front of the rectum. The size of the prostate changes with age. In younger men, it is about the size of a walnut, but it can be much larger in older men.

Prostate Cancer Risk FactorsResearchers have found several factors that might affect a man’s risk of getting prostate cancer.

Age: Prostate cancer is rare in men younger than 40, but the chance of having prostate cancer rises rapidly after age 50. About 6 in 10 prostate cancers are found in men older than 65. The average age at the time of diagnosis is about 66.

Race/ethnicity: Prostate cancer occurs more often in African-American men and Caribbean men of African ancestry than in men of other races. African-American men are also more than twice as likely to die of prostate cancer than white men. Prostate cancer occurs less often in Asian-American and Hispanic/Latino men than in non-Hispanic whites.

Geography: Prostate cancer is most common in North America, northwestern Europe, Australia, and on Caribbean islands. It is less common in Asia, Africa, Central America, and South America.

Family history: Prostate cancer seems to run in some families, which suggests that in some cases there may be an inherited or genetic factor. (Still, most prostate cancers occur in men without a family history of it.) Having a father or brother with prostate cancer more than doubles a man’s risk of developing this disease. (The risk is higher for men who have a brother with the disease than for those who have a father with it.) The risk is much higher for men with several affected relatives, particularly if their relatives were young when the cancer was found.

Prostate cancer can often be found early by testing for prostate-specific antigen (PSA) levels in a man’s blood. Another way to find prostate cancer early is the digital rectal exam (DRE). If the results of either one of these tests are abnormal, further testing is often done to see if a man has cancer. If prostate cancer is found as a result of screening with the PSA test or DRE, it will probably be at an earlier, more treatable stage than if no screening were done.

https://www.cancer.org/content/dam/CRC/PDF/Public/8793.00.pdf https://www.cancer.org/cancer/prostate-cancer/early-detection/risk-factors-for-prostate-cancer.html

MALE:

Prostate

Colon

Lung and Bronchus

Skin

Hematopoietic (cancers of the blood, bone marrow and lymph systems)

2017 Top 5 Hall-Perrine Cancer Center Sites By GenderSource: HPCC Registry Note

FEMALE:

Breast

Colon

Lung and Bronchus

Thyroid

Hematopoietic (cancers of the blood, bone marrow and lymph systems)

* Based on number of cases from January 1, 2017, to August 31, 2017

5

Comprehensive Prostate Care – Mercy Urology Clinic | Hall-Perrine Cancer Center

Mercy’s Prostate Team:

R. Matthew Smith, MD, UrologistMercy Urology Clinic

Jeremiah Murphy, MD, UrologistMercy Urology Clinic

DIAGNOSISPatients can be referred for evaluation to Mercy’s Urology clinic for prostate cancer screening, diagnosis, and management. The patient is examined by one of three Mercy Urologists, Matthew Smith, MD, Jeremiah Murphy, MD or Nathaly François, MD. The urology team provides comprehensive care reviewing treatment options, initiating therapy, providing surgical intervention and referring to medical and radiation oncology as necessary. Individuals with intermediate to high-risk disease are followed in the Advanced Prostate Cancer Clinic.

Mercy’s new Advanced Prostate Cancer Clinic is held on the last Friday of every month. Collaboration between Mercy’s Urology Clinic and the Hall-Perrine Cancer Center was created to monitor prostate cancer patients treated with ongoing Androgen Deprivation Therapy. During the clinic patients have their PSA drawn, receive education on androgen deprivation therapy, and have their androgen deprivation therapy administered. Our Advanced Prostate Cancer Clinic is an ideal environment for ongoing surveillance of this patient population. If it is determined that androgen deprivation therapy measures are no longer controlling the cancer, appropriate interventions, assessments, and referrals are made for ongoing care.

RADIATION THERAPYIf prostate cancer is determined, radiation treatment may be a treatment option for most patients under the direction of Wook Lee, MD. Current advanced methods such as IMRT and image-guided radiation therapy on the Tomo HD help doctors deliver radiation to the prostate with pinpoint accuracy while avoiding giving radiation to normal tissues such as the bladder and bowel. These methods are expected to increase the effectiveness of radiation therapy while reducing the risk of side effects and complications. Advanced and current technology is also making other forms of radiation therapy more effective for treatment. New computer programs allow doctors to better plan the radiation doses and treatment delivery for brachytherapy using radioactive prostate seeds.

MEDICAL TREATMENTIn addition to surgery, hormone treatment and radiation therapy, some patients may require chemotherapy under the direction of Dr. Samuel Wood, MD.

SURVIVORSHIPAs patients near completion of their initial treatment, they meet with Stephanie Miller, ARNP, for a review of their survivorship care plan. The care plan is a summary of the stage and type of their prostate cancer, treatment details and recommendations for long-term follow-up care and return to good health.

Nathaly François, MD, UrologistMercy Urology Clinic

Wook Lee, MD, Radiation OncologistHall-Perrine Cancer Center

Samuel Wood, MD, Medical OncologistHall-Perrine Cancer Center

Stephanie Miller, ARNP, FNP-BC, MSNOncology Survivorship ProgramHall-Perrine Cancer Center

One Visit – Multiple PhysiciansHall-Perrine Cancer Center’s Multidisciplinary Clinics

With many advances in cancer treatments, we feel it’s important to have a collaborative approach to ensure each patient’s treatment plan is comprehensive and effective.

The goal of the Hall-Perrine Cancer Center’s Multidisciplinary Clinic is to move patients from diagnosis to treatment faster – that’s why our patients see all their doctors in one day, during one appointment. The team is tailored to each patient’s needs and may include a medical oncologist, radiation oncologist, oncologic surgeon, oncology nurse navigator, oncology genetic counselor and other specialists. The patient’s treatment plan is evaluated together as a team to ensure quality care.

BENEFIT TO PATIENTS –✓ See all their oncology physicians during one single visit✓ Specially designed rooms for examination and consultation✓ Shorter time between diagnosis and treatment✓ Faster treatment

Lung Clinic: This clinic is for newly diagnosed lung cancer patients. The specialists providing care in this clinic include a medical oncologist, radiation oncologist, surgical oncologist and a pulmonologist.

Breast Clinic: During Breast Clinic, surgical, medical and radiation oncologists will meet with a newly diagnosed breast cancer patient. A specific treatment plan will be outlined with the patient at the end of the appointment.

GI Clinic: The GI Multidisciplinary Clinic is for new gastrointestinal cancer patients. This clinic brings together a surgical oncologist, medical oncologist and radiation oncologist. Collaboratively, these specialties provide the best comprehensive approach for management of the patient’s cancer.

Thyroid Clinic: Dedicated to the diagnosis and comprehensive care of thyroid cancer, thyroid nodules and other complex thyroid disorders. Our physicians specialize in surgical oncology, endocrinology, radiation oncology and medical oncology.

CLINICS ARE HELD ON THE FOLLOWING DAYS:Lung Clinic: Thursdays afternoons

Breast Clinic: Tuesday afternoons

GI Clinic: Thursday afternoons

Thyroid Clinic: Tuesday mornings



Radiation Oncology: Hall Radiation Center Radiation Oncology of Cedar Rapids

Radiation Oncologists at Hall-Perrine Cancer Center

Janet Merfeld, MD Medical Director

Wook Lee, MD

Since 1956, Mercy’s Hall Radiation Center has been a leader in cancer treatment and the first to offer radiation treatment technology west of the Mississippi River. That legacy continues as the radiation center offers the most comprehensive and advanced technology, including the Varian Trilogy and TrueBeam linear accelerators, TomoTherapy, large bore CT Simulator, state-of-the-art PET/CT scanner, IMRT 3 dimensional radiation, High Dose Rate (HDR) Brachytherapy (Mammosite® and gynecologic implants), and prostate Brachytherapy.

RADIATION THERAPY IN PROSTATE CANCER TEAMDr. Wook Lee is the board certified radiation oncologist at the Hall Radiation Center who specializes in prostate cancer. There are two methods of treating prostate cancer with radiation: brachytherapy and external beam. Each patient’s disease and lifestyle are different, so all options are discussed at the initial consultation at the Hall Radiation Center.

The Brachytherapy program at the Hall-Perrine Cancer Center has been active for over twenty years. Dr. Lee and the experienced board certified medical physics staff at the Hall Radiation Center, intricately plan and implant radioactive I 125 seeds into the prostate. The external beam prostate cancer program at the Hall Radiation Center utilizes TomoTherapy, a treatment delivery system specifically designed to deliver high doses of radiation to the tumor while minimizing dose to the nearby healthy tissue such as the rectum and bladder, increasing cure rates while minimizing side effects.

MEDICAL PHYSICIST IN PROSTATE CANCER TEAMThe medical physicists at the Hall-Perrine Cancer Center manage the safety and quality aspects of the prostate cancer radiation therapy program. Every patient’s disease is different so each patient has their individual plan run through a series of quality assurance tests performed by a board certified medical physicist. This can include advanced calculations or measuring a patient’s treatment directly to ensure that each treatment delivered is accurate and safe or overseeing brachytherapy procedures in the operating room.

FISCAL YEAR 2017 HALL RADIATION TREATMENT STATISTICS:Varian Linear Accelerators: 6609TomoTherapy: 3161Thyroid I-131: 43Brachytherapy Procedures–

Gynecologic HDR: 62MammoSite HDR: 22Prostate seed implants: 5

In 2017, 9913 radiation therapy treatments were administered, 490 new patients were seen and 100 patients returned for additional radiation therapy treatments.

SAFETY AND ACCREDITATIONThe Hall Radiation Center utilizes state of the art linear accelerators to efficiently deliver high levels of dose to the cancer tissue while minimizing dose to nearby healthy tissue thus reducing the incidence of side effects from treatment. The complexity of these machines and the power of high energy radiation require that the Hall-Perrine Staff dedicates time and resources to ensuring that the equipment is functioning correctly and treatments are delivered safely.

All radiation equipment at the Hall Radiation Center is rigorously reviewed by a board certified medical physicist and undergoes daily, weekly, and annual tests. Since every patient’s disease is unique each patient has a radiation treatment plan based on their anatomy, staging, etc. To ensure safety, each plan is reviewed by the physician, physicist, and a radiation therapist prior to any treatments being delivered. Our machine performance is reviewed by a credentialing office at MD Anderson Cancer Center and our clinical work and quality assurance processes are peer reviewed as part of our ACRO accreditation process.

The Hall Radiation Center is the only Radiation Oncology department in Eastern Iowa accredited by the American College of Radiation Oncology (ACRO). The accreditation process involves an onsite survey as well as an extensive chart review by ACRO surveyors.

Undergoing radiation therapy can be intimidating, so we do everything we can to give our patients peace of mind before treatments are delivered.

Medical Oncology

Medical oncology services at Hall-Perrine Cancer Center provide high-quality, expert cancer care and chemotherapy treatment by the practicing physicians of Oncology Associates at Mercy Medical Center. The goal is to provide comprehensive and personalized cancer care to patients using a variety of the latest, most effective therapies. The practice includes four oncologists who also offer services for patients with blood disorders (hematology). Along with their dedicated staff, the physicians work to ensure that patients receive individualized treatment planning, therapy and follow-up care. Oncology Associates at Mercy Medical Center works together with the patient’s support system of family and friends, while providing excellent medical care in the comfort of, or close to, their home community. With that in mind, the oncologists travel to outreach clinics in the surrounding areas, including Anamosa, Independence, Manchester and Vinton. Chemotherapy infusions are provided at the practice’s Manchester Outreach Clinic which enables the continuity of high-quality oncology care for patients with limited access or limited transportation to oncology health services.

FISCAL YEAR 2017 HEMATOLOGY / ONCOLOGY STATISTICS:HPCC Clinic New Patients: 881HPCC Established Clinic Visits: 12658HPCC Infusion Treatments: 13749

Oncology Associates at Mercy Medical Center

Medical Oncologists at Hall-Perrine Cancer Center

Leila Kutteh, MD

Jasmine Nabi, MD

Deb Wilbur, MD Medical Director

Samuel Wood, MDFISCAL YEAR 2017 OUTREACH CLINIC STATISTICS:Outreach Clinic New Patients: 116Outreach Clinic Established Patient Visits: 970Total Outreach Clinic Patients: 1076Outreach Infusions (Manchester, IA) 252

Ann Stroh, DO


Surgical Oncology

Hall-Perrine Cancer Centers Surgical Oncology Department offers the highest level of cancer care under the direction of the only fellowship-trained oncologic surgeon in Cedar Rapids, Dr. Vincent Reid. Dr. Reid has advanced training in surgical oncology and is skilled in the latest surgical procedures, offering patients with cancer the best possible outcomes.

MARGINPROBE® Hall-Perrine Cancer Center was the first hospital in Iowa to use MarginProbe® technology to detect any remaining cancerous tissue during breast cancer surgery. MarginProbe delivers clarity in real-time, reducing doubt and the likelihood of a second surgery. Margin Probe reduces the surgical re-excision rate by 75%. National Average is 18-24% Dr. Reids rate is 6%.

SAVI SCOUT®

SAVI SCOUT is an FDA-cleared device used by surgeons and radiologists to precisely locate and direct the removal of a tumor during a lumpectomy or surgical biopsy procedure. SAVI SCOUT uses non-radioactive, radar technology to provide real-time surgical guidance during breast surgery. Rather than placing a wire immediately before surgery, a reflector is placed in the target tissue up to seven days prior to surgery. During surgery, the technology accurately detects the location of the reflector — and the tumor. The new technology also allows for the incision to be more strategically placed by breastsurgeons, and helps reduce the discomfort associated with needle localization lumpectomy, resulting in better cosmetic outcomes. Mercy is the first hospital in Iowa to offer this technology as a standard of care for breast cancer surgery patients.

HIDDEN SCAR™

Hidden Scar Breast Cancer Surgery is an advanced approach in which breast surgeons remove cancerous tissue through a single incision made in inconspicuous areas to minimize visible scarring. By utilizing this approach, surgeons are able to preserve a natural-looking breast by sparing the nipple, areola and surrounding tissue. The Hidden Scar approach may also ease the emotional impact of breast cancer surgery, in that patients have little to no visible reminder of the surgery, and experience a more natural looking breast reconstruction. Patients who undergo this approach are also at no higher risk of recurrence than patients who undergo any other type of technique.

MEMBER OF NATIONAL QUALITY MEASURES FOR BREAST CENTERS (NQMBC)The NQMBC - Surgeon Program identifies quality care measures that allows participating surgeons to compare performance with other participating surgeons across the United States. Dr. Reid is the only surgical oncologist in Iowa that is a member of the NQMBC Surgeon program.

Vincent Reid, MD, FACS Medical Director

Surgical Oncology at Mercy Medical Center

Surgical Oncologist at Hall-Perrine Cancer Center

SURGICAL ONCOLOGY STATISTICS:JANUARY 1, 2013 – AUGUST 31, 2017Total number of surgeries: 1923Lumpectomies: 387Mastectomies: 186


Source: http://www.public-health.uiowa.edu/shri/wp-content/uploads/2016/12/Cancer_in_Iowa_2017.pdf

The cancer registry information is submitted to the State Health Registry of Iowa and the National Cancer Database (NCDB) for research and statistical purposes. The Cancer Registry complies with data standards regulated by the American College of Surgeons Commission on Cancer (ACOS or ACoS)) and the Surveillance Epidemiology and End Results (SEER) program of the National Cancer Institute (NCI). Iowa is a population-based registry established by SEER and NCI as a source for cancer incidence and survival data for 28% of the U.S. population. The development, ongoing growth and support of the registry shows the commitment of the Hall-Perrine Cancer Center as it continues to provide high-quality, comprehensive care for its cancer patients.

CANCER REGISTRY The Hall-Perrine Cancer Registry was established in 1988 to collect data for all hospital patients diagnosed and treated at the facility for cancer. To date, the Hall-Perrine Cancer Registry has more than 22,000 patient records in its database. Data collection of cancer diagnosis and treatment is an important part of a successful cancer program to monitor patient care outcomes. A Certified Tumor Registrar (CTR) collects demographics, pathology, radiology and treatment information on each cancer patient diagnosed and treated at Hall-Perrine Cancer Center. This information is reportable by the Iowa State Health Department regulations. The data provides medical staff and administrators with statistical information for research investigation, facility utilization assessments, the allocation of resources and patient care outcome improvements.

RESEARCHFor nearly 30 years, Oncology Associates at Mercyhave been participating in clinical research studiesfunded through the National Cancer Institute.Clinical trials are an important step in finding newand better ways of treating cancer. Hall-PerrineCancer Center is dedicated to advancing cancercare by leading and participating in many clinicaltrials that test the safety and efficacy of new ormodified cancer treatments. As a member of theIowa-Wide Oncology Research Coalition NCORP,Oncology Associates at Mercy and Mercy MedicalCenter participate in clinical trials offered throughthe Alliance for Clinical Trials in Oncology, theEastern Cooperative Oncology Group (ECOG), NRGOncology, Wake Forest NCORP Research Base, andthe Cancer Trials Support Unit (CTSU). In 2016,research conducted at Oncology Associates at Mercyand Mercy Medical Center included participation inbiorepository, prevention and treatment studies.Quality of life, observation and pre-registrationstudies were conducted there as well. These studieswere conducted via the NCI’s National Clinical TrialsNetwork and pharmaceutical based research.

CANCER CONFERENCEHall-Perrine Cancer Center held 75 cancer conferences in 2017. These conferences provide physicians with the opportunity for discussion of diagnosis, tumor staging, treatment and outcomes of cancer patients. Treatment recommendations are made to provide the highest quality of care. Representatives from the major disciplines including medical oncology, radiation oncology, surgery, pathology, plastic surgery and radiology participate in discussing diagnostic and therapeutic alternatives for the cancer patient.

Top 10 Types of Cancer in Iowa Estimated for 2017

New Cancers in Females # of % of Type Cancers Total

Breast 2300 26.7

Lung 1100 12.8

Colon & Rectum 800 9.3

Uterus 600 7.0

Skin Melanoma 390 4.5

Thyroid 350 4.1

Non-Hodgkin Lymphoma 340 4.0

Leukemia 250 2.9

Pancreas 240 2.8

Kidney & Renal Pelvis 240 2.8

All Others 1990 23.1

Total 8600

New Cancers in Males # of % of Type Cancers Total

Prostate 1500 17.0

Lung 1260 14.3


Bladder (invasive and noninvasive) 630 7.1




Leukemia 380 4.3

Oral Cavity 300 3.4

Pancreas 250 2.8


Total 8800

Cancer Deaths in Females # of % of Type Cancers Total

Lung 740 25.5

Breast 370 12.8


Pancreas 200 6.9

Ovary 150 5.2

Uterus 120 4.1


Leukemia 100 3.4

Brain 80 2.8


All Others 680 23.4

Total 2900

Cancer Deaths in Males # of % of Type Cancers Total

Lung 930 28.3

Prostate 300 9.1


Pancreas 220 6.7

Esophagus 140 4.2

Leukemia 140 4.2


Bladder 120 3.6


Liver 110 3.3

All Others 820 24.9

Total 3300

Top 10 Types of Cancer in Iowa Estimated for 2017New Cancers in Females # of % of Type Cancers Total

Breast 2300 26.7

Lung 1100 12.8


Uterus 600 7.0


Thyroid 350 4.1


Leukemia 250 2.9

Pancreas 240 2.8



Total 8600

New Cancers in Males # of % of Type Cancers Total

Prostate 1500 17.0

Lung 1260 14.3


Bladder (invasive and noninvasive) 630 7.1




Leukemia 380 4.3

Oral Cavity 300 3.4

Pancreas 250 2.8


Total 8800

Cancer Deaths in Females # of % of Type Cancers Total

Lung 740 25.5

Breast 370 12.8


Pancreas 200 6.9

Ovary 150 5.2

Uterus 120 4.1


Leukemia 100 3.4

Brain 80 2.8


All Others 680 23.4

Total 2900

Cancer Deaths in Males # of % of Type Cancers Total

Lung 930 28.3

Prostate 300 9.1


Pancreas 220 6.7

Esophagus 140 4.2

Leukemia 140 4.2


Bladder 120 3.6


Liver 110 3.3

All Others 820 24.9

Total 3300

Top 10 Types of Cancer in Iowa Estimated for 2017


DIETITIANNutrition plays an important role in the care and healing of individuals with cancer. Individualized nutrition assessment and education is offered to each patient during their cancer treatment. The nutrition services are provided by a Board-Certified Specialist in Oncology Nutrition (CSO). Board certification as a specialist in oncology helps to identify a registered dietitian with a specialized skill set as a nutrition expert for patients who are seeking timely, accurate and reliable information on eating well before, during or after cancer treatment. In 2017, the Hall-Perrine Cancer Center dietitian completed 1230 nutrition visits and presented 7 community outreach programs.

SOCIAL WORKERCancer treatment and care involves not only medical care but attention to the emotional and psychosocial issues of the patient and family. At the Hall-Perrine Cancer Center, the social worker can provide assistance through ongoing supportive care, practical issues, community resources and referrals.

SYMPTOMS INCLUDE:✓ Tingling, burning, coldness, weakness

or numbness in the hands or feet.

✓ Pain or difficulty walking.

✓ Difficulty picking up small objects, buttoning, typing, etc.

Hall-Perrine Cancer Center Support Services

CANCER PATIENT REHABILITATION Hall-Perrine Cancer Center offers a full range ofrehabilitation and support services for cancerpatients, including physical therapy, breast therapy,occupational therapy and speech therapy, with thegoal of maximizing and enhancing the quality ofcancer survivorship.

✓ Physical therapy provides individualized solutions to improve/maintain maximum strength, balance and mobility, including the use of specialized exercises, assistive devices such as canes and walkers and caregiver education.

✓ Breast cancer therapy offers support and treatment to patients with lymphedema and axillary web syndrome. Additional services include garment and prosthetic fitting from our certified mastectomy fitter.

✓ Occupational therapy provides specialized services in breast cancer rehabilitation, exercise instruction to prevent limitations in upper extremities, lymphedema prevention and treatment, scar massage and patient/caregiver training in adaptive equipment to maximize independence.

✓ Speech/swallowing therapy provides specialized services to head and neck cancer patients, optimizing the safety and efficiency of oral intake and development of assistive communication devices and prescription exercises to inhibit fibrotic tissue changes following surgery and radiation therapy.

INFRARED LIGHT THERAPYInfrared Light Therapy is used to treat patients with neuropathy, pain and poor circulation caused by a range of factors including chemotherapy, diabetes, acute injuries and vascular disease. This non-invasive, evidence-based therapy emits monochromatic infrared light, which increases circulation and triggers the local release of nitric oxide to promote healing and decrease pain and inflammation. This therapy provides symptomatic relief while avoiding systemic side effects.

NURSE NAVIGATORThe role of the Nurse Navigator is to ease the burden of cancer treatment on both the patient and family. They coordinate the efforts of the medical team, help patients and families understand their diagnosis and assist them through the healthcare system. They also participate in weekly Multidisciplinary clinics, support groups and cancer conference. There is no cost to utilize the services of the Nurse Navigator as it is part of the Hall-Perrine Cancer Center’s comprehensive cancer care.

THRIVE THERAPY FITNESS AND WELLNESS PROGRAMThrive Fitness and Wellness is a program designed to improve a patient’s functional strength and exercise ability during and following the course of their cancer treatments. A physical therapist will perform an initial assessment to determine any weakness in daily activities, balance or walking stability issues, as well as measure the patient’s exercise ability. An individualized program is developed and then implemented by specially trained exercise instructors.

RENEW IMAGE CENTERBeyond the state-of-the-art technology in the Hall-Perrine Cancer Center you’ll find ReNew, a holistic image center providing patients with services focused on treating the whole person – during and after treatment. Services include a salon providing products and hair services as well as post mastectomy products and fittings.

PALLIATIVE CAREPalliative Care is specialized care for those experiencing a serious, progressive or life-limiting illness. The goal of Palliative Care is to relieve the pain, symptoms and stress of a serious illness to achieve the best quality of life, while supporting patients and their families, regardless of treatment goals and life expectancy. The Palliative Care Program is an integral part of Hall-Perrine Cancer Center’s comprehensive cancer care.


GENETICS AND CANCER RISK ASSESSMENTApproximately ten percent of cancers are hereditary. This means that individuals are born at a higher than average risk to develop cancer. By identifying individuals and families that have a hereditary cancer syndrome, we can discuss additional cancer surveillance and also preventative strategies. The Genetics and Cancer Risk Assessment Program helps patients assess, understand, and manage their risk of developing cancer. During the free genetic consultation, the patient meets with our High Risk Genetics Nurse Practitioner, and discusses personal cancer risks, education regarding preventative measures to decrease those risks, early detection procedures, and the benefits and limitations of genetic testing. Cancer risk assessment is beneficial to estimate individuals’ risks for cancer in their lifetime. Women may be at risk for breast cancer solely based on a family history of breast cancer even when genetic test is negative. Breast cancer risk assessment and estimating risk for breast cancer may change an individual’s breast cancer screening recommendations. Additional services, such as DNA banking, participation in research studies, and providing support and resources to patients and families are also available. Assistance with insurance coverage issues is also provided. Since its inception, the program has served more than 1,500 individuals. The High Risk Genetics Nurse Practitioner participates in Multidisciplinary Clinics within our cancer center. We have worked to educate the public and other healthcare professionals on issues related to cancer genetic counseling and genetic testing through educational presentations.

MERCY WOMEN’S CENTERMercy Women’s Center is designated by the American College of Radiology (ACR) as a Breast ImagingCenter of Excellence. The Center provides breast care screening and diagnostic services, including DigitalMammography, Digital Breast Tomosynthesis (3-D Imaging), which offers the latest state of the art imaging,diagnostic mammography, Molecular Breast Imaging; ultrasound; nonsurgical breast biopsies; and educationabout early detection of breast cancer. Specially-trained Registered Nurses offers education, resources andsupport to individuals newly diagnosed with breast cancer. A dedicated breast nurse navigator acts as a casemanager for each newly diagnosed breast cancer patient from diagnosis through treatment and beyond.Since 1991, free mammograms and other breast care services have been provided to area women in needthrough the Especially For You® Race Against Breast Cancer. In 2013, Mercy’s Women’s Center becamea participant in the National Quality Measure for Breast Centers Program (NQMBC). This program identifiesquality core measures, and provides immediate access to information and allows breast centers to comparetheir performance with others across the U.S.

SUPPORT GROUPSHall-Perrine Cancer Center offers monthly support groups for patients. The support group meetings provide patients with a time and place to connect with others facing the same challenges. These meetings provide a forum to educate, share thoughts and address issues related to cancer treatment and survivorship.


Survivorship Program

WHAT’S NEXT ONCE YOU HAVE FINISHED YOUR TREATMENT FOR CANCER?Hall-Perrine Cancer Center’s Survivorship Program assists patients with the transition from being in active treatment. Patients will be educated regarding changes they have experienced during treatment or may encounter post treatment, along with resources to aid in regaining overall health and well-being. Ask your doctor or nurse for an appointment.

WHAT TO EXPECT AT A SURVIVORSHIP PROGRAM APPOINTMENT:

✓ Review your treatment summary

✓ Coordinate care with your other physicians

✓ Discuss effects of cancer and its therapy

✓ Improve quality of life

✓ Provide monitoring recommendations

✓ Review National Comprehensive Cancer Network (NCCN) guidelines for follow-up care

✓ Discuss a wellness plan/lifestyle changes in order to promote a healthy well-being

MAKE APPROPRIATE REFERRALS TO:

✓ Thrive Fitness & Wellness program

✓ Counseling

✓ Cancer genetics

✓ Support groups

✓ Smoking cessation

✓ Pulmonary rehabilitation

✓ Physical or occupational therapy

✓ Dietitian


Community Events & Education

Sponsorship and involvement in cancer-related community events allow Hall-Perrine Cancer Center to give back to the community while raising awareness and funding for cancer research. In conjunction with the American Cancer Society and other community agencies, Hall-Perrine Cancer Center sponsors annual cancer screenings and programs for the community at large. The programs for 2017 included:

✓ Especially For You® Breast Cancer Support Group

✓ Multiple Myeloma Support Group

✓ Thrive Cancer Fitness & Wellness Program

✓ Journey to Wellness Activities

✓ Breast Cancer Education

✓ Skin Cancer Screening

✓ Prostate Cancer Screening

✓ Gems of Hope Monthly Workshops

✓ American Cancer Society – Look Good Feel Better

✓ Especially For You® Race Against Breast Cancer

✓ Mercy Medical Center’s Power of Pink

✓ Hall-Perrine Cancer Center Survivors Day

✓ American Cancer Society - Relay for Life

✓ Gems of Hope - Daffodil Days

✓ Dental Cancer Conferences

✓ Especially For You® Womens Health and Well-being Events

✓ Colon Cancer Education

✓ Back to School Back Packs – In partnership with Aiming for a Cure

✓ Baskets of Hope - In partnership with Aiming for a Cure

✓ Prom Skin Cancer Prevention and Education Event

✓ Smoking Cessation Program

✓ Low Dose CT Lung Cancer Screening

* The Support Group and Community Events and Education section meet the requirements for the Commission on Cancer standards 4.1 and 4.2.

CONNECT, SHARE & LEARN WITH USHall-Perrine Cancer Center

701 10th Street SE Cedar Rapids, IA 52403

(319) 365-HOPE

www.hallperrinecancercenter.org

Documents

2017 - Hall-Perrine Cancer Center · of their survivorship care plan. The care plan is a summary of the stage and type of their prostate cancer, treatment details and recommendations